Name

TAFAZZIN Gene

tafazzin, phospholipid-lysophospholipid transacylase

This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known. [provided by RefSeq, Jul 2008]

Tafazzin Gene Set

From InterPro Predicted Protein Domain Annotations

proteins predicted to have the Tafazzin protein domain from the InterPro Predicted Protein Domain Annotations dataset.

TAFAZZIN Gene Set

From LINCS L1000 CMAP CRISPR Knockout Consensus Signatures

genes differentially expressed following the TAFAZZIN gene perturbation from the LINCS L1000 CMAP CRISPR Knockout Consensus Signatures dataset.

TAFAZZIN Gene Set

From CM4AI KOLF21J CRISPRi Gene Perturbation Atlas

genes differentially expressed following the TAFAZZIN gene perturbation from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas.

Caused by mutation in the tafazzin gene Gene Set

From ClinVar Gene-Phenotype Associations 2025

genes associated with the Caused by mutation in the tafazzin gene phenotype from the curated ClinVar Gene-Phenotype Associations 2025 dataset.